In T2DM patients, there is a disruption of the glucose transport stimulated by insulin, which regulates the transport of blood glucose through interaction with the insulin substrate receptor protein (ISR-1/2) [10], and PRKCZ participates in the occurrence and development of T2DM through insulin signaling pathway mechanisms. This evidence concerns the gene INS and type 2 diabetes mellitus.